Selective epithelial expression of KRASG12D in the Oncopig pancreas drives ductal proliferation and desmoplasia that is accompanied by an immune response
Abstract Pancreatic ductal adenocarcinoma (PDAC) remains a formidable challenge in oncology, characterized by a high mortality rate, largely attributable to delayed diagnosis and the intricacies of its tumor microenvironment. Innovations in modeling pancreatic epithelial transformation provide valua...
Saved in:
Main Authors: | Carlos P. Jara, Al-Murtadha Al-Gahmi, Audrey Lazenby, Michael A. Hollingsworth, Mark A. Carlson |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-87178-2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
KRASG12C‐inhibitor‐based combination therapies for pancreatic cancer: insights from drug screening
by: Constanza Tapia Contreras, et al.
Published: (2025-02-01) -
MRTX1133 attenuates KRASG12D mutated-colorectal cancer progression through activating ferroptosis activity via METTL14/LINC02159/FOXC2 axis
by: Junwei Zou, et al.
Published: (2025-02-01) -
Carbapenem-resistant Enterobacterales (CRE) colonisation as a predictor for subsequent CRE infection: A retrospective surveillance study
by: Courtney M. Tubb, et al.
Published: (2025-01-01) -
Minimally invasive determination of pancreatic ductal adenocarcinoma (PDAC) subtype by means of circulating cell‐free RNA
by: Martin Metzenmacher, et al.
Published: (2025-02-01) -
Risk factors for Carbapenem-resistant Enterobacterales infections: A case-control study
by: Sibongakonke Mbele, et al.
Published: (2025-02-01)